[Evaluation of a specific French scale of activity in chronic heart failure. A national multicenter study. Group for Cardiac Insufficiency and Cardiomyopathy of the French Society of Cardiology].

Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62

Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J (2009) 6.64

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09

Predicting sudden death in the population: the Paris Prospective Study I. Circulation (1999) 3.80

Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation (2001) 3.12

Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood (2001) 2.87

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73

Myoblast transplantation for heart failure. Lancet (2001) 2.71

A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet (1994) 2.71

Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.52

Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med (2000) 2.28

Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res (1997) 2.25

Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J (1998) 2.20

Subxiphoid pericardiocentesis guided by contrast two-dimensional echocardiography in cardiac tamponade: experience of 110 consecutive patients. Eur J Echocardiogr (2000) 2.13

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation (1998) 2.04

A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J (2000) 2.03

Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest (1990) 1.94

Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J (1998) 1.91

Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology (2000) 1.81

Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J (1998) 1.79

Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet (1993) 1.74

Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73

Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart (1997) 1.72

Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J (2000) 1.68

New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am J Roentgenol (2001) 1.66

[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. Int J Cardiol (2013) 1.55

Polyvisceral echinococcosis with cardiac involvement imaged by two-dimensional echocardiography, computed tomography and nuclear magnetic resonance imaging. Am J Cardiol (1987) 1.51

Invasive monitoring combined with two-dimensional echocardiographic study in septic shock. Intensive Care Med (1994) 1.51

Muscle strength and body composition in adult women with Marfan syndrome. Rheumatology (Oxford) (2007) 1.47

Linkage analysis of five fibrillar collagen loci in a large French Marfan syndrome family. J Med Genet (1990) 1.45

[Negative D-dimers and peripheral pulmonary embolism]. Arch Mal Coeur Vaiss (2003) 1.42

Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet (2008) 1.41

Dynamic cardiomyoplasty: effect of discontinuing latissimus dorsi muscle stimulation on left ventricular systolic and diastolic performance and exercise capacity. J Am Coll Cardiol (1995) 1.39

[Prognostic factors in dilated cardiomyopathies]. Arch Mal Coeur Vaiss (1988) 1.38

[Definitions and classification of cardiomyopathies]. Arch Mal Coeur Vaiss (1996) 1.38

Left ventricular volume analysis for the detection of coronary artery disease during dobutamine stress echocardiography in patients undergoing vascular surgery. Eur J Echocardiogr (2000) 1.38

Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology (1999) 1.38

Inter-study variability in left ventricular mass measurement. Comparison between M-mode echography and MRI. Eur Heart J (1992) 1.38

Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet (2001) 1.37

Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet (2003) 1.37

Molecular basis of familial cardiomyopathies. Circulation (1995) 1.36

Risk stratification in chronic heart failure. Eur Heart J (1998) 1.33

Echocardiographic pattern of acute cor pulmonale. Chest (1997) 1.33

Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology (2006) 1.30

Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet (1995) 1.29

In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation (2004) 1.29

[Prevalence and management of heart failure in France: national study among general practitioners of the Sentinelles network]. Rev Med Interne (2005) 1.28

Left coronary artery aneurysm and anteroseptal acute myocardial infarction following blunt chest trauma. Eur Heart J (1986) 1.27

Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol (1992) 1.27

Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med (Berl) (1998) 1.27

Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation (1999) 1.25

Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy. Neurology (2008) 1.20

Coincidence of two genetic forms of Charcot-Marie-Tooth disease in a single family. Neurology (2004) 1.20

Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation (1996) 1.18

Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol (2000) 1.18

Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res (2001) 1.15

[Rupture of the interventricular septum in myocardial infarct]. Actual Cardiol Angeiol Int (Paris) (1970) 1.15

Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology (2007) 1.13

Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med (2001) 1.13

Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene. J Clin Invest (1993) 1.13

Exclusion of HRAS from long QT locus. Nat Genet (1994) 1.11

Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis (2007) 1.11

Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts. J Clin Invest (1991) 1.11

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation (1997) 1.10

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09

Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol (1999) 1.09